Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

211 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY).
Chisari CG, Bianco A, Brescia Morra V, Calabrese M, Capone F, Cavalla P, Chiavazza C, Comi C, Danni M, Filippi M, Iaffaldano P, Lanzillo R, Lo Fermo S, Lucisano A, Lugaresi A, Lus G, Marfia GA, Marinelli F, Mirabella M, Moiola L, Perin C, Realmuto S, Toscano S, Trojano M, Vecchio D, Patti F; Italian MS Registry. Chisari CG, et al. Among authors: moiola l. Neurotherapeutics. 2023 Oct;20(6):1696-1706. doi: 10.1007/s13311-023-01415-y. Epub 2023 Aug 23. Neurotherapeutics. 2023. PMID: 37610702 Free PMC article.
Disease-modifying drugs in childhood-juvenile multiple sclerosis: results of an Italian co-operative study.
Ghezzi A, Amato MP, Capobianco M, Gallo P, Marrosu G, Martinelli V, Milani N, Milanese C, Moiola L, Patti F, Pilato V, Pozzilli C, Trojano M, Zaffaroni M, Comi G; Immunomodulatory Treatment of Early onset MS Group. Ghezzi A, et al. Among authors: moiola l. Mult Scler. 2005 Aug;11(4):420-4. doi: 10.1191/1352458505ms1206oa. Mult Scler. 2005. PMID: 16042224 Clinical Trial.
Treatment of early-onset multiple sclerosis with intramuscular interferonbeta-1a: long-term results.
Ghezzi A, Amato MP, Capobianco M, Gallo P, Marrosu MG, Martinelli V, Milanese C, Moiola L, Milani N, La Mantia L, Patti F, Pozzilli C, Trojano M, Comi G, Zaffaroni M; Immunomodulatory Treatment of Early-onset MS (ITEMS) Group. Ghezzi A, et al. Among authors: moiola l. Neurol Sci. 2007 Jun;28(3):127-32. doi: 10.1007/s10072-007-0804-2. Epub 2007 Jun 30. Neurol Sci. 2007. PMID: 17603763 Clinical Trial.
Evidence of thalamic gray matter loss in pediatric multiple sclerosis.
Mesaros S, Rocca MA, Absinta M, Ghezzi A, Milani N, Moiola L, Veggiotti P, Comi G, Filippi M. Mesaros S, et al. Among authors: moiola l. Neurology. 2008 Mar 25;70(13 Pt 2):1107-12. doi: 10.1212/01.wnl.0000291010.54692.85. Epub 2008 Feb 13. Neurology. 2008. PMID: 18272867
Long-term results of immunomodulatory treatment in children and adolescents with multiple sclerosis: the Italian experience.
Ghezzi A, Amato MP, Annovazzi P, Capobianco M, Gallo P, La Mantia L, Marrosu MG, Martinelli V, Milani N, Moiola L, Patti F, Pozzilli C, Trojano M, Zaffaroni M, Comi G; ITEMS (Immunomodulatory Treatment of Early-onset MS) Group. Ghezzi A, et al. Among authors: moiola l. Neurol Sci. 2009 Jun;30(3):193-9. doi: 10.1007/s10072-009-0083-1. Epub 2009 Apr 22. Neurol Sci. 2009. PMID: 19387545 Clinical Trial.
Brain macro- and microscopic damage in patients with paediatric MS.
Absinta M, Rocca MA, Moiola L, Ghezzi A, Milani N, Veggiotti P, Comi G, Filippi M. Absinta M, et al. Among authors: moiola l. J Neurol Neurosurg Psychiatry. 2010 Dec;81(12):1357-62. doi: 10.1136/jnnp.2010.205682. Epub 2010 Jul 26. J Neurol Neurosurg Psychiatry. 2010. PMID: 20660915
Safety and efficacy of natalizumab in children with multiple sclerosis.
Ghezzi A, Pozzilli C, Grimaldi LM, Brescia Morra V, Bortolon F, Capra R, Filippi M, Moiola L, Rocca MA, Rottoli M, Sarchielli P, Zaffaroni M, Comi G. Ghezzi A, et al. Among authors: moiola l. Neurology. 2010 Sep 7;75(10):912-7. doi: 10.1212/WNL.0b013e3181f11daf. Neurology. 2010. PMID: 20820002 Free article. Clinical Trial.
211 results